Monday, October 9, 2017

Quidel Closes On Acquisition Of Assets From Alere

San Diego-based diagnostic testing equipment maker Quidel has closed on its acquisition of Alere's Triage cardiovascular and toxicology business, the company said on Friday, in a deal worth up to $680M in total. Auqidel said it paid $400M in cash plus up to $280M in deferred consideration for Alere's B-type Naturietic Peptide (BNP) assay business. The deal had been originally announced on July 17th.